Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 10.12
+1.10 (12.20%)
Nov 6, 2026, 4:00 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 214.71 million as of November 6, 2026. It is the 22,080th most valuable company in the world and the 559th biggest in Canada. Its market cap has increased by 65.35% in one year.
Market Cap
214.71M
Enterprise Value
126.89M
Revenue
n/a
Global Rank
Country Rank
#559 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 214.71M, an increase of 264.96%. That is a compound annual growth rate of 28.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 214.71M | 75.37% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 624.79M |
| Bright Minds Biosciences | 257.55M |
| Eastwood Bio-Medical Canada | 130.88M |
| Helix BioPharma | 70.27M |
| NurExone Biologic | 46.27M |
| Thiogenesis Therapeutics | 44.09M |
| Sharp Therapeutics | 43.26M |
| Medicenna Therapeutics | 40.15M |